Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant NOVO NORDISK A/S, against the decision of the State Institute for Drug Control from 21. 9. 2016, under the no. SUKLS156092/2016 - 

The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

This document describes the key findings for the Czech Republic from the OECD Skills Strategy 2019.

 

Více na: OECD.org - Czech Republic

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant MZ ČR Celltrion Healthcare Hungary Kft., against the decision of the State Institute for Drug Control from 27. 3. 2019, under the no. SUKLS256885/2017 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant HEATON k.s., Glenmark Pharmaceuticals s.r.o., against the decision of the State Institute for Drug Control from 29. 8. 2016, under the no. SUKLS161848/2016 - I. under article 90 paragraph 4 in connection with article 66 paragraph 1 letter f) of the Administration Code the operative part 7 of the decision under appeal is dismissed and the proceedings are terminated. II. under article 90 paragraph 5 of the Administrative Code the appeals are dismissed and the rest of the decisions under appeal are upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Pfizer Limited, against the decision of the State Institute for Drug Control from 31. 8. 2016, under the no. SUKLS218001/2013 - The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)

 

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of Prices and Reimbursements for Medicinal Products and Foods for Special Medicinal Purposes (“List”).

 

Více na: EN SUKL - List of reimbursed medicinal products

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant PRO.MED.CS Praha a.s., Zentiva, k.s., Takeda GmbH, against the decision of the State Institute for Drug Control from 30. 6. 2016, under the no. SUKLS203870/2014 - I. under article 90 paragraph 4 in connection with article 66 paragraph 2 of the Administrative Code the operative part 4, 5, 10, 11, 17, 18, 30, 31, 32, 33, 50, 53, 54, 58, 60, 64, 73, 83, 84, 85, 86, 87, 88, 89, 95, 96 of the decision under appeal is dismissed and the proceedings are terminated. II. under article 90 paragraph 5 of the Administrative Code the appeals are dismissed and the rest of the decisions under appeal are upheld.

More information: MZCR.cz (czech version only)

 

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Svaz zdravotních pojišťoven, against the decision of the State Institute for Drug Control from 29. 6. 2016, under the no. SUKLS111007/2015 - I. The appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz (czech version only)